Anticytokine therapy in preterm labor: Current knowledge and future perspectives

Gynecologic and Obstetric Investigation

Volumn 71, Issue 1, 2011, Pages 1-10

  Sado, Toshiyuki ^a   Kitanaka, Takashi ^a   Naruse, Katsuhiko ^a   Oi, Hidekazu ^a   Noguchi, Taketoshi ^a   Yoshida, Shozo ^a   Kajihara, Hirotaka ^a   Shigetomi, Hiroshi ^a   Oonogi, Akira ^a   Kobayashi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bikunin; Cytokine; NF B; Preterm labor; TNF ; Toll like receptor

Indexed keywords

ADALIMUMAB; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; FIBRONECTIN; GAMMA INTERFERON; GELATINASE A; GELATINASE B; GESTONORONE CAPROATE; GOLIMUMAB; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90; HYDROXYPROGESTERONE; INDOMETACIN; INFLIXIMAB; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAGNESIUM SULFATE; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYTOCIN ANTAGONIST; PROGESTERONE; RITODRINE; SALAZOSULFAPYRIDINE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ULINASTATIN;

AMINO TERMINAL SEQUENCE; AMNION; AMNION FLUID; CROHN DISEASE; DISEASE MODEL; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; FETUS DISEASE; FETUS MEMBRANE; FETUS TACHYCARDIA; GESTATIONAL AGE; HEADACHE; HEART PALPITATION; HUMAN; INFLAMMATION; INTRAUTERINE INFECTION; NONHUMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; TH1 CELL; TH2 CELL; UMBILICAL CORD; UTERINE CERVIX MUCUS; VAGINITIS; VOMITING;

ANIMALS; CYTOKINES; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY;

EID: 78651417673     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317268     Document Type: Review

References (47)

1. Noguchi A: Lowering the premature birth rate: what the US experience means for Japan. Keio J Med 2008; 57: 45-49.
2. Goldenberg RL, Culhane JF, Iams JD, Romero R: Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84.
3. Goldenberg RL, Goepfert AR, Ramsey PS: Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol 2005; 192:S36-S46.
4. McElrath TF, Hecht JL, Dammann O, Boggess K, Onderdonk A, Markenson G, Harper M, Delpapa E, Allred EN, Leviton A, ELGAN Study Investigators: Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am J Epidemiol 2008; 168: 980-989.
5. Anum EA, Springel EH, Shriver MD: Genetic contributions to disparities in preterm birth. Pediatr Res 2009; 65: 1-9.
6. Ananth CV, Vintzileos AM: Medically indicated preterm birth: recognizing the importance of the problem. Clin Perinatol 2008; 35: 53-67.
7. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chaiworapongsa T, Mazor M: The preterm parturition syndrome. BJOG. 2006; 113(suppl 3):17-42.
8. Thomson AJ, Telfer JF, Young A, Campbell S, Stewart CJ, Cameron IT, Greer IA, Norman JE: Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod 1999; 14: 229-236.
9. Mueller-Heubach E, Rubinstein DN, Schwarz SS: Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 1990; 75: 622-626.
10. Andrews WW, Goldenberg RL, Faye-Petersen O, Cliver S, Goepfert AR, Hauth JC: The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol 2006; 195: 803-808.
11. Massaro G, Scaravilli G, Simeone S, Capuano S, Pastore E, Forte A, Parisi P, Ferraiolo A, Costanzo A, Balbi C: Interleukin-6 and Mycoplasma hominis as markers of preterm birth and related brain damage: our experience. J Matern Fetal Neonatal Med 2009; 22: 1063-1067.
12. Holst RM, Hagberg H, Wennerholm UB, Skogstrand K, Thorsen P, Jacobsson B: Prediction of spontaneous preterm delivery in women with preterm labor: analysis of multiple proteins in amniotic and cervical fluids. Obstet Gynecol 2009; 114: 268-277.
13. Keeler SM, Kiefer DG, Rust OA, Vintzileos A, Atlas RO, Bornstein E, Hanna N: Comprehensive amniotic fluid cytokine profile evaluation in women with a short cervix: which cytokine(s) correlates best with outcome? Am J Obstet Gynecol 2009; 201: 276.e1-e6.
14. Houben ML, Nikkels PG, van Bleek GM, Visser GH, Rovers MM, Kessel H, de Waal WJ, Schuijff L, Evers A, Kimpen JL, Bont L: The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS One 2009; 4:e6572.
15. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F: Inflammation and pregnancy. Reprod Sci 2009; 16: 206-215.
16. Liu H, Redline RW, Han YW: Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J Immunol 2007; 179: 2501-2508.
17. Mendelson CR: Minireview: fetal-maternal hormonal signaling in pregnancy and labor. Mol Endocrinol 2009; 23: 947-954.
18. Cockle JV, Gopichandran N, Walker JJ, Levene MI, Orsi NM: Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications. Reprod Sci 2007; 14: 629-645.
19. Kendal-Wright CE: Stretching, mechanotransduction, and proinflammatory cytokines in the fetal membranes. Reprod Sci 2007; 14: 35-41.
20. Patni S, Flynn P, Wynen LP, Seager AL, Morgan G, White JO, Thornton CA: An introduction to Toll-like receptors and their possible role in the initiation of labour. BJOG. 2007; 114: 1326-1334.
21. Canavan TP, Simhan HN: Innate immune function of the human decidual cell at the maternal-fetal interface. J Reprod Immunol 2007; 74: 46-52.
22. Simhan HN, Chiao JP, Mattison DR, Caritis SN: Human decidual cell Toll-like receptor signaling in response to endotoxin: the effect of progestins. Am J Obstet Gynecol 2008; 198: 119.e1-e4.
23. O'Neill LA: Primer: Toll-like receptor signaling pathways - what do rheumatologists need to know? Nat Clin Pract Rheumatol 2008; 4: 319-327.
24. Adams Waldorf KM, Persing D, Novy MJ, Sadowsky DW, Gravett MG: Pretreatment with Toll-like receptor 4 antagonist inhibits lipopolysaccharide- induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod Sci 2008; 15: 121-127.
25. Tsan MF, Gao B: Heat shock proteins and immune system. J Leukoc Biol 2009; 85: 905-910.
26. Chaiworapongsa T, Erez O, Kusanovic JP, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Than NG, Mittal P, Kim YM, Camacho N, Edwin S, Gomez R, Hassan SS, Romero R: Amniotic fluid heat shock protein 70 concentration in histologic chorioamnionitis, term and preterm parturition. J Matern Fetal Neonatal Med 2008; 21: 449-461.
27. Molvarec A, Tamási L, Losonczy G, Madách K, Prohászka Z, Rigó J Jr: Circulating heat shock protein 70 (HSPA1A) in normal and pathological pregnancies. Cell Stress Chaperones 2009;15:237-247.
28. Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM: Fetal fibronectin as a shortterm predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol 2009; 114: 631-640.
29. Sato TA, Keelan JA, Mitchell MD: Critical paracrine interactions between TNF-α and IL-10 regulate lipopolysaccharide-stimulated human choriodecidual cytokine and prostaglandin E2 production. J Immunol 2003; 170: 158-166.
30. Scrivo R, Conti F, Spinelli FR, Truglia S, Magrini L, Di Franco M, Ceccarelli F, Valesini G: Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature. Reumatismo 2009; 61: 107-117.
31. Hoentjen F, van Bodegraven AA: Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. World J Gastroenterol 2009; 15: 2067-2073.
32. Holmgren C, Esplin MS, Hamblin S, Molenda M, Simonsen S, Silver R: Evaluation of the use of anti-TNF-α in an LPS-induced murine model. J Reprod Immunol 2008; 78: 134-139.
33. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR: Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 2385-2392.
34. Mano Y, Shibata K, Sumigama S, Hayakawa H, Ino K, Yamamoto E, Kajiyama H, Nawa A, Kikkawa F: Tocilizumab inhibits interleukin- 6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes. Gynecol Obstet Invest 2009; 68: 145-153.
35. Kobayashi H: Endogenous anti-inflammatory substances, inter-α -inhibitor and bikunin. Biol Chem 2006; 387: 1545-1549.
36. Kanayama S, Yamada Y, Onogi A, Shigetomi H, Ueda S, Tsuji Y, Haruta S, Kawaguchi R, Yoshida S, Sakata M, Sado T, Kitanaka T, Oi H, Yagyu T, Kobayashi H: Molecular structure and function analysis of bikunin on down-regulation of tumor necrosis factor-α expression in activated neutrophils. Cytokine 2008; 42: 191-197.
37. Suzuki M, Kobayashi H, Tanaka Y, Hirashima Y, Kanayama N, Takei Y, Saga Y, Suzuki M, Itoh H, Terao T: Bikunin target genes in ovarian cancer cells identified by microarray analysis. J Biol Chem 2003; 278: 14640-14646
38. Futamura Y, Kajikawa S, Kaga N, Shibutani Y: Protection against preterm delivery in mice by urinary trypsin inhibitor. Obstet Gynecol 1999; 93: 100-108.
39. Wakahara K, Kobayashi H, Yagyu T, Matsuzaki H, Kondo T, Kurita N, Sekino H, Inagaki K, Suzuki M, Kanayama N, Terao T: Bikunin suppresses lipopolysaccharide-induced lethality through down-regulation of tumor necrosis factor-α and interleukin-1β in macrophages. J Infect Dis 2005; 191: 930-938.
40. Imada K, Ito A, Kanayama N, Terao T, Mori Y: Urinary trypsin inhibitor suppresses the production of interstitial procollagenase/ proMMP-1 and prostromelysin 1/ proMMP-3 in human uterine cervical fibroblasts and chorionic cells. FEBS Lett 1997; 417: 337-340.
41. Kaga N, Katsuki Y, Obata M, Shibutani Y: Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstet Gynecol 1996; 174: 754-759.
42. Kaga N, Katsuki Y, Futamura Y, Obata M, Shibutani Y: Role of urinary trypsin inhibitor in the maintenance of pregnancy in mice. Obstet Gynecol 1996; 88: 872-882.
43. Katsuki Y, Kaga N, Kakinuma C, Takagaki K, Kajikawa S, Shibutani Y: Ability of intrauterine bacterial lipopolysaccharide to cause in situ uterine contractions in pregnant rabbits. Acta Obstet Gynecol Scand 1997; 76: 26-32.
44. Sakamoto S, Takeda Y, Nakabayashi M: Advances in perinatal medical care - from our experience. Int J Gynaecol Obstet 1998; 63(suppl 1):S107-S114.
45. Sakamoto S, Terao T: How to lower perinatal mortality? Perinatal care in Japan. Croat Med J 1998; 39: 197-207.
46. El Maradny E, Kanayama N, Halim A, Maehara K, Kobayashi T, Terao T: Effects of urinary trypsin inhibitor on myometrial contraction in term and preterm deliveries. Gynecol Obstet Invest 1996; 41: 96-102.
47. Chandiramani M, Shennan A: Preterm labour: update on prediction and prevention strategies. Curr Opin Obstet Gynecol 2006; 18: 618-624.